Transcriptomics

Dataset Information

Combined VEGFR and MAPK pathway inhibition in angiosarcoma


ABSTRACT: Combined inhibition of the VEGF and MAPK pathways with cediranib and trametinib had an additive effect in in vitro models, and a combinatorial effect in an in vivo model. Combined treatment led to smaller tumors than treatment with either agent alone. RNA-seq demonstrated distinct expression signatures between the trametinib treated tumors and those treated with both trametinib and cediranib.

ORGANISM(S): Mus musculus

PROVIDER: GSE165234 | GEO | 2022/01/19

REPOSITORIES: GEO